Cipla Ltd. (CIPLA): Cipla Share Price Rises 2.17% Today as Stock Gains
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Cipla Share Price moved higher today, with Cipla Ltd. trading at Rs 1,401.25, up 2.17% from the previous close of Rs 1,371.45. The company’s market capitalisation stands at Rs 1,10,793.75 crore, which gives the move a large-cap setting in the healthcare space. The day’s gain was Rs 29.8, and the stock finished near its session high of Rs 1,402.5 after opening at Rs 1,384.7. The low for the day was Rs 1,383.75, so the session stayed within a relatively tight band. In that sense, the latest Cipla Share Price update reflects a controlled rise rather than an erratic swing.
The supplied data confirms a price-rise event, but it does not identify a company-specific catalyst. For that reason, the cleanest reading of Cipla Stock News today is that the stock saw a verified same-day advance while remaining within its broader fundamental and peer context. The turnover of Rs 1.24 crore helps frame the session as a measurable market event, but it should not be interpreted as a reason for the move. Investors following Cipla Share Price Today can therefore focus on what is known: the rise, the trading range, the valuation profile and the industry backdrop.
Cipla Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,401.25 |
| Previous Close | Rs 1,371.45 |
| Today's Move | Rs 29.8 (+2.17%) |
| Open | Rs 1,384.7 |
| High | Rs 1,402.5 |
| Low | Rs 1,383.75 |
| Turnover | Rs 1.24 crore |
| Market Capitalisation | Rs 1,10,793.75 crore |
| Market Cap Category | Large Cap |
Cipla Ltd. (CIPLA) rose to Rs 1,401.25 from the previous close of Rs 1,371.45, a move of Rs 29.8 or 2.17%. The stock opened at Rs 1,384.7, reached a high of Rs 1,402.5, recorded a low of Rs 1,383.75.
Cipla Share Price action was straightforward in today’s trade. The stock opened above the previous close, stayed broadly firm through the session, and ended almost at the day’s peak. That shape matters because it shows that the gain was held into the close instead of fading late in the day. A session that closes close to the high often signals that buyers remained active through the trading window, even when the article cannot attribute the move to any specific announcement or event.
For readers scanning Cipla Share Price Today, the important numbers are the current price of Rs 1,401.25, the previous close of Rs 1,371.45, and the absolute change of Rs 29.8. The stock’s intraday high of Rs 1,402.5 was only slightly above the closing price, which suggests a finish near the strongest point of the session. Meanwhile, the intraday low of Rs 1,383.75 and the open of Rs 1,384.7 indicate that the stock spent most of the day trading in a relatively narrow zone around the mid-Rs 1,390s to Rs 1,400 mark.
That trading pattern gives the Cipla Share Price rise a useful quality: it was not just a brief spike. Instead, the stock moved up early, consolidated within a controlled range, and remained elevated at the close. This is why the session is worth attention even in the absence of a clear headline catalyst. Investors who track Cipla Stock Performance usually look for whether a gain is supported by steady intraday behaviour, and today’s numbers show that the stock managed to hold almost all of its upside into the final print.
The turnover of Rs 1.24 crore is the only trading-flow detail supplied, and it should be viewed carefully as context rather than a trend signal. It tells us that today’s move happened with real market participation, but it does not reveal the breadth of market interest or the intensity of order flow. Even so, when paired with the narrow gap between the high and the closing price, it supports the conclusion that Cipla Share Price ended the day on a firm note.
Another reason this price action matters is that it keeps Cipla in the conversation for investors reviewing short-term relative strength in the healthcare universe. A 2.17% gain is meaningful, especially when it comes after a prior close at Rs 1,371.45. At the same time, the move is still modest enough to remain within the bounds of normal market variation. So, while Cipla Share Price has advanced, the data supports a measured interpretation rather than an overstated one.
Cipla Ltd. (CIPLA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,10,793.75 crore |
| P/E Ratio | 32.87x |
| P/B Ratio | 3.15x |
| ROE | 11.83% |
| ROCE | 16% |
| EPS | Rs 41.72 |
| Book Value Per Share | Rs 435.18 |
| Dividend Yield | 0.95% |
Cipla Ltd. (CIPLA) fundamental metrics show P/E 32.87x, P/B 3.15x, ROE 11.83%, ROCE 16%. These figures provide context only and are not a buy or sell signal.
Cipla Ltd. has a market capitalisation of Rs 110793.75 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 32.87x, P/B at 3.15x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.83% and ROCE of 16%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 41.72, book value per share of Rs 435.18, dividend yield of 0.95%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 32.87x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 3.15x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 11.83% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 16% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 1,10,793.75 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Cipla Ltd. (CIPLA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Cipla Ltd. (CIPLA) has a P/E ratio of 32.87x, which is equal to the benchmark median of 32.87x, a difference of 0%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Cipla Ltd. (CIPLA) has a ROE of 11.83%, which is above the benchmark median of 11.7%, a difference of +1.11%. Cipla Ltd. (CIPLA) has a ROCE of 16%, which is above the benchmark median of 13.46%, a difference of +18.87%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,05,644.55 | 96.62 | 18.73 | 18.31 | 18.2 |
Cipla Ltd. (CIPLA) has a P/E ratio of 32.87x compared with the displayed peer median of 83.79x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.83% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 16% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Cipla Ltd. (CIPLA) has a market capitalisation of Rs 1,10,793.75 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Cipla
- Cipla Share Price rose 2.17% today to Rs 1,401.25 after closing at Rs 1,371.45 in the previous session.
- The stock’s market capitalisation is Rs 1,10,793.75 crore, giving Cipla a large-cap healthcare context.
- Cipla’s P/E ratio is 32.87 and P/B ratio is 3.15, keeping valuation central to the analysis.
- ROE is 11.83% and ROCE is 16%, both above the same-industry benchmark medians.
- The stock closed near its session high, which supports the strength of today’s price action.
About Cipla
Cipla Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company belongs to a mature listed universe where investors often compare earnings, book value and return ratios before drawing conclusions from a daily share-price move. That is why the latest Cipla Share Price update is best understood as part of a broader financial profile rather than as an isolated number.
The available data shows a company with a substantial market presence, a known earnings base and a dividend yield that can be tracked alongside valuation. For readers who regularly check Cipla Stock News or Cipla News Today, those are the core pieces of context that matter. The stock’s size, profitability and peer position are all visible in the supplied figures, which makes the current price rise easy to place within the company’s broader market identity.
Track Cipla Share Price on Univest
Use Cipla Ltd. (CIPLA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Cipla Share Price can be followed on Univest for live updates, sector context and company-level comparison. Investors often use a combination of the live share-price page, the top-gainers screener and market blogs to monitor whether today’s move is being followed by broader strength or simply stands as a single-session event. For a stock like Cipla, that kind of tracking is especially useful because daily movement can look different once viewed alongside the wider healthcare universe.
The current article is designed to keep the focus on verified data only. It highlights the same-day gain, the trading range, the basic valuation metrics and the peer backdrop without making unsupported claims. In that way, readers can use Cipla Share Price as a factual starting point for further research rather than as a substitute for it.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Cipla Share Price rising today?
Ans. Cipla Share Price rose 2.17% today to Rs 1,401.25. The supplied data confirms the gain, but it does not identify any company-specific catalyst, so the movement should be treated as a verified same-day price rise.
What is Cipla Share Price today?
Ans. Cipla Share Price today is Rs 1,401.25, compared with the previous close of Rs 1,371.45. The stock also recorded a day’s high of Rs 1,402.5 and a day’s low of Rs 1,383.75 during the session.
How does Cipla look on valuation?
Ans. Cipla has a P/E ratio of 32.87 and a P/B ratio of 3.15. In the same-industry benchmark, the P/E matches the median, while the P/B sits slightly above the median of 3.08.
How does Cipla compare with sector peers?
Ans. Cipla’s P/E of 32.87 is below several higher-valued pharma peers shown in the data, while its ROCE of 16% is above the same-industry median. That creates a balanced peer comparison for investors.
What are Cipla’s key fundamental numbers?
Ans. Cipla’s key fundamental numbers include market capitalisation of Rs 1,10,793.75 crore, EPS of Rs 41.72, book value per share of Rs 435.18, ROE of 11.83% and dividend yield of 0.95%.
Where can investors track Cipla Share Price on Univest?
Ans. Investors can track Cipla Share Price on Univest through live stock pages, market blogs and top-gainers tools. These pages help readers compare today’s movement with sector and peer context in one place.
